Iovance Biotherapeutics reported early pilot trial results for lifileucel in aggressive soft tissue sarcomas. The company plans to start a registrational trial and seek expedited FDA approval based on ...
Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ​improved survival in a late‑stage trial, ‌meeting the study's main goal. The oral drug mezigdomide, when used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results